EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Naringenin targets FimZ to regulate type I fimbriae and reduce the virulence of Salmonella

Qingqing Meng, Guizhen Wang, Jiahui Lu, Yifan Duan, Jingyao Wen, Manli Zhang, Feng Hu, Min Rao

Frontiers in Cellular and Infection Microbiology · 17.12.2025 · 15

DOI: 10.3389/fcimb.2025.1649866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 17.12.2025. Verfasst von Qingqing Meng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, The first Hospital of Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Flavanones, Fimbriae Proteins, Fimbriae, Bacterial, Salmonella typhimurium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salmonella infection severely affects the healthy development of livestock and poultry, as well as food safety and public health. The critical role of type I fimbriae (TIFs) in promoting Salmonella pathogenicity makes them important targets for exploring inhibitors of Salmonella infection. In this study, we found that naringenin (Nar) inhibited the invasion of Salmonella into HeLa cells but did not affect bacterial motility. Nar reduced the transcription levels of the TIF structural proteins FimA and FimH and the chaperone proteins FimC and FimD, as determined via RT–qPCR. Molecular docking and surface plasmon resonance (SPR) assays confirmed that Nar was bound to FimZ, which directly regulates the expression of TIF, resulting in a reduction in TIF formation accompanied by a decrease in biofilm formation and bacterial adhesion to cells and alleviation of the inflammatory response. In vivo , Nar prolonged the survival of mice infected with Salmonella , improved the survival rate, reduced the inflammation level and bacterial load, and significantly alleviated histopathological damage. These results provide alternative strategies and promising lead compounds for controlling Salmonella infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesFimbriae ProteinsFimbriae, BacterialSalmonella typhimuriumSalmonellaAnti-Bacterial AgentsAnimalsHumansHeLa CellsBacterial AdhesionVirulenceMiceSalmonella InfectionsMolecular Docking SimulationGene Expression Regulation, BacterialBiofilmsDisease Models, AnimalFemaleMice, Inbred BALB C

Stichwörter der Autor:innen

FimZNARSalmonellainflammationtype I fimbriae

Substanzen

naringeninFlavanonesFimbriae ProteinsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Hepatology and Gastroenterology, The first Hospital of Jilin University, Changchun, Jilin, China.
  • College of Biological and Food Engineering, Jilin Engineering Normal University, Changchun, China.

Zitieren

APA

Meng, Q., Wang, G., Lu, J., Duan, Y., Wen, J., Zhang, M., Hu, F., & Rao, M. (2025). Naringenin targets FimZ to regulate type I fimbriae and reduce the virulence of Salmonella. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1649866

Vancouver

Meng Q, Wang G, Lu J, Duan Y, Wen J, Zhang M, et al. Naringenin targets FimZ to regulate type I fimbriae and reduce the virulence of Salmonella. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1649866

BibTeX
@article{Meng2025,
  author = {Meng, Qingqing and Wang, Guizhen and Lu, Jiahui and Duan, Yifan and Wen, Jingyao and Zhang, Manli and Hu, Feng and Rao, Min},
  title = {Naringenin targets FimZ to regulate type I fimbriae and reduce the virulence of Salmonella},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1649866}
}
Kostenlos starten →